Sila Realty SILA Q4 2025 Earnings Call Transcript
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 6 days ago
0mins
Should l Buy SILA?
Source: NASDAQ.COM
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy SILA?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on SILA
Wall Street analysts forecast SILA stock price to rise
1 Analyst Rating
1 Buy
0 Hold
0 Sell
Moderate Buy
Current: 25.940
Low
28.00
Averages
28.00
High
28.00
Current: 25.940
Low
28.00
Averages
28.00
High
28.00
About SILA
Sila Realty Trust, Inc. is a real estate investment trust. The Company is primarily focused on investing in high-quality healthcare facilities across the continuum of care, which the Company believes typically generates predictable, durable and growing income streams. Its portfolio comprises tenants in geographically diverse facilities, which are positioned to capitalize on the dynamic delivery of healthcare to patients. The Company owns approximately 136 real estate properties, and two undeveloped land parcels located in 66 markets across the United States. Its portfolio includes Akron Healthcare Facility, Alexandria Healthcare Facility, Allen Healthcare Facility, Appleton Healthcare Facility, Augusta Healthcare Facility, Beaumont Healthcare Facility, Bellevue Healthcare Facility, Carrollton Healthcare Facility, Cincinnati Healthcare Facility, Yukon Healthcare Facility, El Segundo Healthcare Facility, Dallas Healthcare Facility, Pleasant Hills Healthcare Facility, and others.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Sila Realty Trust Q4 2025 Earnings Call Insights
- Growth Strategy Execution: Sila Realty Trust acquired six healthcare facilities in 2025 for approximately $150 million, adding 241,000 rentable square feet that align with the company's modern construction standards, thereby enhancing its competitive position in the healthcare real estate market.
- Strong Financial Performance: Cash NOI for 2025 reached $169.9 million, reflecting a 0.8% year-over-year increase, while FFO per share rose to $2.16, a 3.6% improvement from the previous year, indicating sustained revenue and profitability growth.
- Successful Lease Renewals: The lease renewal rate remained at 90% in 2025, with the weighted average remaining lease term increasing to 10 years, and tenant credit quality improved to 40.6%, providing a solid foundation for future stable income.
- Flexible Capital Allocation: Management anticipates investing between $225 million and $375 million in 2026, emphasizing the importance of maintaining liquidity while continuing to optimize the asset portfolio to capitalize on market changes and opportunities arising from an aging population.
See More
Sila Realty SILA Q4 2025 Earnings Call Transcript
See More
Sila Realty Trust Q4 Earnings Beat Expectations
- Earnings Beat: Sila Realty Trust reported a Q4 FFO of $0.55, exceeding expectations by $0.04, indicating strong profitability in a stable healthcare rental market.
- Significant Revenue Growth: The company achieved $50.7 million in revenue for Q4, an 8.9% year-over-year increase, surpassing market expectations and demonstrating effective expansion strategies.
- Attractive Yield: Offering a 7% yield, Sila Realty Trust remains appealing to income-seeking investors despite market skepticism, enhancing its competitive position in the REIT sector.
- Top Small-Cap Performer: Recognized as one of the top ten small-cap stocks with the highest dividend growth, Sila Realty Trust showcases superior performance and investment appeal within the small-cap REIT landscape.
See More
Sila Realty Trust Reports Key 2025 Financial Highlights
- Acquisition Activity: In 2025, Sila successfully acquired six high-quality healthcare properties for approximately $149 million, which play a critical role in the social infrastructure of their respective patient communities, enhancing the company's asset portfolio and market position.
- Cash NOI Growth: The cash NOI for Q4 2025 was $44 million, up 7.3% from $41 million in Q4 2024, primarily driven by acquisitions and a same-store cash NOI growth of 0.7%, indicating the company's sustained growth potential in the healthcare real estate sector.
- Financial Stability: As of December 31, 2025, Sila's liquidity was nearly $500 million, with a net debt to annualized EBITDA ratio of 3.9x, demonstrating the company's strong financial flexibility and robust capital structure for future investment opportunities.
- Shareholder Returns: In Q4 2025, Sila reported an AFFO of $30.4 million, or $0.55 per share, with a dividend payout ratio of 72.6%, reflecting the company's commitment to returning value to shareholders while maintaining healthy cash flow and profitability.
See More
Sila Realty Trust Reports Strong 2025 Financial Results
- Net Income Performance: For Q4 2025, Sila reported a net income of $5.0 million, or $0.09 per diluted share, down from $11.1 million in Q4 2024, reflecting challenges in market competition while underscoring its ongoing investment strategy in healthcare real estate.
- Cash NOI Growth: The cash net operating income for Q4 2025 reached $44.0 million, a 7.3% increase year-over-year, primarily driven by newly acquired healthcare properties and same-store cash NOI growth, indicating effective asset management and stable market demand.
- Annual Dividend Policy: The company declared a cash dividend of $1.60 per share for 2025, with a quarterly dividend of $0.40, demonstrating a commitment to shareholder returns and reflecting its stable cash flow and profitability.
- Portfolio Expansion: As of December 31, 2025, Sila owned 140 properties with approximately 5.3 million rentable square feet and a leasing rate of 98.7%, indicating a strong position in the healthcare real estate market and significant growth potential moving forward.
See More
Sila Realty Trust to Release Q4 2025 Financial Results
- Earnings Release Schedule: Sila Realty Trust will issue its Q4 and full-year 2025 financial results after market close on February 24, 2026, highlighting the company's performance in the healthcare investment sector.
- Analyst Conference Call: A conference call will be held on February 25, 2026, at 11:00 a.m. ET to discuss the financial results and answer analyst questions, enhancing transparency and investor confidence.
- Portfolio Overview: As of September 30, 2025, Sila owned 140 real estate properties and three undeveloped land parcels across 67 U.S. markets, demonstrating its extensive footprint and market penetration in the healthcare sector.
- Strategic Focus: Sila's investment strategy centers on high-quality healthcare facilities aimed at generating predictable, durable, and growing income streams, reflecting the company's strategic advantage in the dynamic delivery of healthcare services.
See More
Sila Realty Trust Q4 2025 Earnings Call Insights
- Growth Strategy Execution: Sila Realty Trust acquired six healthcare facilities in 2025 for approximately $150 million, adding 241,000 rentable square feet that align with the company's modern construction standards, thereby enhancing its competitive position in the healthcare real estate market.
- Strong Financial Performance: Cash NOI for 2025 reached $169.9 million, reflecting a 0.8% year-over-year increase, while FFO per share rose to $2.16, a 3.6% improvement from the previous year, indicating sustained revenue and profitability growth.
- Successful Lease Renewals: The lease renewal rate remained at 90% in 2025, with the weighted average remaining lease term increasing to 10 years, and tenant credit quality improved to 40.6%, providing a solid foundation for future stable income.
- Flexible Capital Allocation: Management anticipates investing between $225 million and $375 million in 2026, emphasizing the importance of maintaining liquidity while continuing to optimize the asset portfolio to capitalize on market changes and opportunities arising from an aging population.
See More
Sila Realty SILA Q4 2025 Earnings Call Transcript
See More
Sila Realty Trust Q4 Earnings Beat Expectations
- Earnings Beat: Sila Realty Trust reported a Q4 FFO of $0.55, exceeding expectations by $0.04, indicating strong profitability in a stable healthcare rental market.
- Significant Revenue Growth: The company achieved $50.7 million in revenue for Q4, an 8.9% year-over-year increase, surpassing market expectations and demonstrating effective expansion strategies.
- Attractive Yield: Offering a 7% yield, Sila Realty Trust remains appealing to income-seeking investors despite market skepticism, enhancing its competitive position in the REIT sector.
- Top Small-Cap Performer: Recognized as one of the top ten small-cap stocks with the highest dividend growth, Sila Realty Trust showcases superior performance and investment appeal within the small-cap REIT landscape.
See More
Sila Realty Trust Reports Key 2025 Financial Highlights
- Acquisition Activity: In 2025, Sila successfully acquired six high-quality healthcare properties for approximately $149 million, which play a critical role in the social infrastructure of their respective patient communities, enhancing the company's asset portfolio and market position.
- Cash NOI Growth: The cash NOI for Q4 2025 was $44 million, up 7.3% from $41 million in Q4 2024, primarily driven by acquisitions and a same-store cash NOI growth of 0.7%, indicating the company's sustained growth potential in the healthcare real estate sector.
- Financial Stability: As of December 31, 2025, Sila's liquidity was nearly $500 million, with a net debt to annualized EBITDA ratio of 3.9x, demonstrating the company's strong financial flexibility and robust capital structure for future investment opportunities.
- Shareholder Returns: In Q4 2025, Sila reported an AFFO of $30.4 million, or $0.55 per share, with a dividend payout ratio of 72.6%, reflecting the company's commitment to returning value to shareholders while maintaining healthy cash flow and profitability.
See More
Sila Realty Trust Reports Strong 2025 Financial Results
- Net Income Performance: For Q4 2025, Sila reported a net income of $5.0 million, or $0.09 per diluted share, down from $11.1 million in Q4 2024, reflecting challenges in market competition while underscoring its ongoing investment strategy in healthcare real estate.
- Cash NOI Growth: The cash net operating income for Q4 2025 reached $44.0 million, a 7.3% increase year-over-year, primarily driven by newly acquired healthcare properties and same-store cash NOI growth, indicating effective asset management and stable market demand.
- Annual Dividend Policy: The company declared a cash dividend of $1.60 per share for 2025, with a quarterly dividend of $0.40, demonstrating a commitment to shareholder returns and reflecting its stable cash flow and profitability.
- Portfolio Expansion: As of December 31, 2025, Sila owned 140 properties with approximately 5.3 million rentable square feet and a leasing rate of 98.7%, indicating a strong position in the healthcare real estate market and significant growth potential moving forward.
See More
Sila Realty Trust to Release Q4 2025 Financial Results
- Earnings Release Schedule: Sila Realty Trust will issue its Q4 and full-year 2025 financial results after market close on February 24, 2026, highlighting the company's performance in the healthcare investment sector.
- Analyst Conference Call: A conference call will be held on February 25, 2026, at 11:00 a.m. ET to discuss the financial results and answer analyst questions, enhancing transparency and investor confidence.
- Portfolio Overview: As of September 30, 2025, Sila owned 140 real estate properties and three undeveloped land parcels across 67 U.S. markets, demonstrating its extensive footprint and market penetration in the healthcare sector.
- Strategic Focus: Sila's investment strategy centers on high-quality healthcare facilities aimed at generating predictable, durable, and growing income streams, reflecting the company's strategic advantage in the dynamic delivery of healthcare services.
See More
